Helen S. Marshall

University of Adelaide - Vaccinology and Immunology Research Trials Unit

72 King William Rd

North Adelaide

Australia

  • University of Adelaide - Vaccinology and Immunology Research Trials Unit

SCHOLARLY PAPERS

7

DOWNLOADS

391

TOTAL CITATIONS

0

Scholarly Papers (7)

Actions:
Email selected abstracts
1.

The Platform Trial in COVID-19 Priming and Boosting (PICOBOO): The Immunogenicity, Reactogenicity, and Safety of Different COVID-19 Vaccinations Administered as a Second Booster (Fourth Dose) in Azd1222 Primed Individuals Aged 50-<70 Years Old

Number of pages: 13 Posted: 07 May 2024
Charlie McLeod, Michael Dymock, Katie Flanagan, Magdalena Plebanski, Helen S. Marshall, Marie J. Estcourt, Ushma Wadia, Christian Tjiam, Christopher Blyth, Kanta Subbarao, Francesca L. Mordant, Suellen Nicholson, Saul N. Faust, Ruth B. Thornton, Anne McKenzie, Julie A. Marsh, Thomas Snelling and Peter Richmond
Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, University of Tasmania - School of Health Sciences and School of Medicine, Royal Melbourne Institute of Technolog (RMIT University), University of Adelaide - Vaccinology and Immunology Research Trials Unit, The University of Sydney, Perth Children's Hospital - Department of Infectious Diseases, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, University of Melbourne - Department of Microbiology and Immunology (DMI), Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, Charles Darwin University - Menzies School of Health Research and The University of Western Australia
Downloads 97 (541,087)

Abstract:

Loading...

Adaptive platform trial, COVID-19, vaccines, Bayesian, immunisation, policy

2.

A Phase I, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Trial to Study the Safety and Immunogenicity of a DNA-Based Vaccine Against COVID-19 (COVIGEN) in Healthy SARS-CoV-2 Vaccine-Naïve Participants Aged 18 to 59 Years Old

Number of pages: 38 Posted: 21 Mar 2024
Nick Wood, Ushma Wadia, Peter Richmond, Chris Argent, Helen S. Marshall, Kerrie J. Sandgren, Katie Tungatt, Gabriela Martins Costa Gomes, Will Asquith, Janette Taylor, Matthew V. O'Sullivan, Dominic Dwyer, Anita H.J. van den Biggelaar, Laurent Dapremont, Souad Mansouri, Pham Hong Thai and Anthony L. Cunningham
Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, The University of Western Australia, Scientia Clinical Research Ltd, University of Adelaide - Vaccinology and Immunology Research Trials Unit, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - NSW Health Pathology, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, Technovalia Pty. Ltd., Technovalia Pty. Ltd., BioNet-Asia Co Ltd and The University of Sydney - Westmead Institute for Medical Research
Downloads 81 (600,638)

Abstract:

Loading...

DNA, SARS-CoV-2, vaccine, neutralising antibody, COVID-19, safety, immunogenicity

3.

The Platform Trial in COVID-19 Priming and BOOsting (PICOBOO): The Immunogenicity, Reactogenicity, and Safety of Licensed COVID-19 Vaccinations Administered as a Second Booster in BNT162b2 Primed Individuals Aged 18-<50 and 50-<70 Years Old

Number of pages: 39 Posted: 08 Jul 2024
Charlie McLeod, Michael Dymock, Katie Flanagan, Magdalena Plebanski, Helen S. Marshall, Marie J. Estcourt, Ushma Wadia, Christian Tjiam, Christopher Blyth, Kanta Subbarao, Francesca L. Mordant, Suellen Nicholson, Natalie Cain, Rianne Brizuela, Saul N. Faust, Ruth B. Thornton, Anne McKenzie, Julie A. Marsh, Thomas Snelling and Peter Richmond
Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, University of Tasmania - School of Health Sciences and School of Medicine, Royal Melbourne Institute of Technolog (RMIT University), University of Adelaide - Vaccinology and Immunology Research Trials Unit, The University of Sydney, Perth Children's Hospital - Department of Infectious Diseases, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, University of Melbourne - Department of Microbiology and Immunology (DMI), Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, Charles Darwin University - Menzies School of Health Research and The University of Western Australia
Downloads 74 (631,443)

Abstract:

Loading...

COVID-19, Booster Vaccines, Immunogenicity, adaptive platform trial, health policy.

4.

A Phase 2 Study of the Immunogenicity, Safety, and Tolerability of MenB-FHbp, a Bivalent Meningococcal B Vaccine, in Healthy Toddlers

Number of pages: 142 Posted: 18 Dec 2018
Helen S. Marshall, Timo Vesikari, Peter C. Richmond, Leszek Szenborn, Johannes Beeslaar, Jason D. Maguire, Joseph Eiden, Kathrin U. Jansen, Judith Absalon, Graham Crowther, Roger Maansson, Thomas R. Jones, Shannon L. Harris, Laura J. York, Su-San Lee, John L. Perez and B1971035 Study Investigators
University of Adelaide - Vaccinology and Immunology Research Trials Unit, Tampere University, The University of Western Australia, Wroclaw Medical University, Pfizer Vaccine Clinical Research and Development, Pfizer Vaccine Clinical Research and Development, Pfizer Vaccine Clinical Research and Development, Pfizer Vaccine Clinical Research and Development, Pfizer Vaccine Clinical Research and Development, Pfizer Vaccine Clinical Research and Development, Pfizer Vaccine Clinical Research and Development, Pfizer Vaccine Clinical Research and Development, Pfizer Vaccine Clinical Research and Development, Pfizer Vaccine Clinical Research and Development, University of Adelaide - Vaccinology and Immunology Research Trials Unit, Pfizer Vaccine Clinical Research and Development and Independent
Downloads 42 (831,645)

Abstract:

Loading...

5.

Real World Impact of 13vPCV in Preventing Invasive Pneumococcal Pneumonia in Australian Children: A National Study

Number of pages: 29 Posted: 28 Mar 2022
Nusrat Homaira, Roxanne Strachan, Helen Quinn, Sean Beggs, Mejbah Bhuiyan, Asha Bowen, Laura K. Fawcett, lyn gilbert, Stephen B. Lambert, Kristine Macartney, Helen S. Marshall, Andrew C. Martin, Gabrielle McCallum, Angela McCullagh, Tim McDonald, Hiran Selvadurai, Peter McIntyre, Shahin Oftadeh, Sarath Ranganathan, Thomas Saunders, Sadasivam Suresh, Claire Wainwright, Angela Wilson, Melanie Wong, Adam Jaffe and Thomas Snelling
University of New South Wales (UNSW) - School of Women’s and Children’s Health, Sydney Children's Hospital - Respiratory Department, Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Royal Hobart Hospital - Paediatric Department, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, University of New South Wales (UNSW) - School of Women’s and Children’s Health, Institute of Clinical Pathology and Medical Research - Centre for Infectious Diseases-Public Health, Queensland Paediatric Infectious Diseases Laboratory - Children’s Health Queensland, Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), University of Adelaide - Vaccinology and Immunology Research Trials Unit, Perth Children's Hospital - Department of General Paediatrics, Charles Darwin University - Child Health Division, Monash Children’s Hospital - Department of Respiratory Medicine, The Centenary Hospital, Children’s Hospital at Westmead, Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Institute of Clinical Pathology and Medical Research - Centre for Infectious Diseases-Public Health, The University of Melbourne, University of Melbourne - Department of Respiratory and Sleep Medicine, University of Queensland - Child Health Research Centre, University of Queensland - Child Health Research Centre, Alice Springs Hospital - Department of Paediatrics, Children’s Hospital at Westmead, University of New South Wales (UNSW) and Charles Darwin University - Menzies School of Health Research
Downloads 41 (824,031)

Abstract:

Loading...

Childhood pneumonia, 13vPCV, vaccine effectiveness

6.

Presentation and Management of Kawasaki Disease in Australia, 2019–21: A Multicentre Prospective Cohort Study

Number of pages: 23 Posted: 31 Oct 2024
Ryan David Lucas, Philip Britton, Nick Wood, Allen C. Cheng, Helen S. Marshall, Ushma Wadia, Joshua Francis, Davinder Singh-Grewal and David Burgner
Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Monash University - Department of Infectious Diseases, University of Adelaide - Vaccinology and Immunology Research Trials Unit, Perth Children's Hospital - Department of Infectious Diseases, Charles Darwin University - Menzies School of Health Research, Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS) and University of Melbourne - Murdoch Children's Research Institute
Downloads 29 (925,139)

Abstract:

Loading...

Kawasaki disease, epidemiology

7.

Effect of 4cmenb Vaccination on the Genomic Epidemiology of Neisseria Meningitidis Oropharyngeal Carriage in an Asymptomatic Adolescent Population

Number of pages: 23 Posted: 19 Apr 2023
Lex EX Leong, Rosa C. Coldbeck-Shackley, Mark McMillan, Holly B. Bratcher, Mark Turra, Andrew J. Lawrence, Charlene Kahler, Martin CJ Maiden, Geraint B. Rogers and Helen S. Marshall
SA Pathology - Public Health Laboratory, Microbiology and Infectious Diseases, SA Pathology, University of Adelaide - School of Medicine, University of Oxford - Department of Biology, SA Pathology, SA Pathology, The University of Western Australia, University of Oxford - Department of Biology, South Australian Health and Medical Research Institute - Microbime & Host Health and University of Adelaide - Vaccinology and Immunology Research Trials Unit
Downloads 27 (944,275)

Abstract:

Loading...

Neisseria meningitidis, vaccination, whole genome sequencing, asymptomatic meningococcal carriage